Related Experiment Video
Updated: Dec 11, 2025

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Impact of Preconception Treatment Initiation for Hypothyroidism on Neurocognitive Function in Children
Qiongjie Zhou1,2, Chunfang Wang1,2, Huan Xu1,2
1Obstetrics and Gynecology Hospital of Fudan University, Shanghai, People's Republic of China.
Insights
Starting levothyroxine before conception did not significantly improve children's cognitive development compared to starting treatment after 8-14 weeks of gestation. This study on maternal hypothyroidism treatment impacts fetal neurodevelopment.
Area of Science:
- Endocrinology
- Neurodevelopmental Pediatrics
- Obstetrics
Background:
- Maternal hypothyroidism in early pregnancy is linked to inconsistent outcomes.
- Levothyroxine treatment timing for hypothyroidism during pregnancy is critical for fetal neurodevelopment.
- Assessing the impact of preconception versus early-gestation treatment is essential.
Purpose of the Study:
- To evaluate the impact of preconception maternal hypothyroidism treatment on fetal neurodevelopment.
- To compare children's cognitive function based on the timing of levothyroxine initiation.
- To determine if early levothyroxine treatment improves neurocognitive outcomes.
Main Methods:
- Prospective, single-center cohort study involving 466 participants.
- Women were divided into preconception (BC) and after conception (AC) treatment groups.
- Neurocognitive development was assessed using the Gesell Development Diagnosis Scale at 6, 12, and 24 months.
Main Results:
- No significant differences in neurocognitive assessment scores between BC and AC groups at 6, 12, or 24 months.
- Slightly lower motor and total scores at 12 months and adaptability at 24 months were observed in the BC group.
- Subgroup analysis for subclinical hypothyroidism showed persistent differences in motor ability and total scores.
Conclusions:
- Preconception levothyroxine treatment did not yield significantly better cognitive outcomes up to age 2.
- Initiating levothyroxine treatment at 8-14 weeks of gestation appears comparable to preconception treatment for neurodevelopment.
- Pregnancy and neonatal outcomes were not significantly different based on treatment timing, severity, or TPO status.
Context:
Levothyroxine treatment for hypothyroidism in early pregnancy has inconsistent outcomes.
Objective:
This study evaluated children's cognitive function to ascertain the impact of preconception maternal hypothyroidism treatment on fetal neurodevelopment.
Design And Setting:
This prospective, single-center cohort study was conducted at a tertiary-care hospital.
Patients:
Women were assigned to the before conception (BC) and after conception (AC; 8-14 gestational weeks) groups by time point of hypothyroidism diagnosis and treatment.
Interventions:
Levothyroxine treatment was adjusted based on results of a monthly thyroid function test.
Main Outcome Measures:
The Gesell Development Diagnosis Scale (GDDS; Chinese version) was used to assess neurocognitive development of children at age 6, 12, and 24 months, with total score as the primary outcome.
Results:
Of the 466 participants, 187 and 279 were in the BC and AC groups, respectively. Both groups were comparable at baseline antenatal visit, except for a higher proportion of thyroid peroxidase (TPO) antibody-positive participants in the BC group (P < .001). No significant intergroup differences were evident on the GDDS neurodevelopmental assessment at age 6, 12, and 24 months (P > .05), except for unexpected slightly lower motor ability (P = .009) and total (P = .026) scores at 12 months and adaptability at 24 months (P = .037) in the BC group. Differences for motor ability (P < .001) and total score (P = .026) persisted on subgroup analysis for subclinical hypothyroidism, without significant differences in pregnancy and neonatal outcomes by severity and TPO status (P > .05).
Conclusions:
Preconception levothyroxine treatment did not induce significantly better cognitive outcomes in children up to age 2 than treatment initiated at 8 to 14 weeks of gestation.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Environmental Influences on Intelligence
Factors Affecting Drug Response: Overview
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Teratogenicity
Information Processing Approach

